Can Li

Institution
University of Hong Kong

Country
Hong Kong

Field
Engineering

Li is a recipient of the 2023 Croucher Tak Wah Mak Innovation Award for his research exploring the limitations of digital computers in performing tasks accomplished by the human brain, including recognising faces, reasoning based on vague information, and learning from experience.

(Photo: University of Hong Kong)

AWARDS
  • 2023 Croucher Tak Wah Mak Innovation Award

Related articles

Keeping A Finger On The Pulse Of Healthcare

Low-cost hardware, combined with wireless technology and state-of-the-art cloud apps, will transform the business of healthcare, says Renew Group CEO Ravinder Sajwan.

Is This Town Big Enough?

What does Singapore’s recent push towards deep technology mean for the country’s more mature life sciences sector?

Building Deep Tech Companies At SGInnovate

SGInnovate, Entrepreneur First and the Singapore-MIT Alliance for Research and Technology Innovation Centre are working together to find and nurture Singapore’s next generation of entrepreneurs.

A Deep Dive Into Water Management Reform

Cooperation between governments and farmers is essential for irrigation policy and water management in Southeast Asia, says SMU Assistant Professor Jacob Ricks.

Systematically Taming The Complexity Of Cancer

By combining biological experiments with supercomputing simulations, scientists have devised a method to identify optimal drug targets for a range of cancers.

Aptamers To Help Reduce Chemotherapy Side Effects

Researchers in Hong Kong have combined aptamers with anticancer drugs to specifically target ovarian cancer cells.

How Fusion Genes Lead To Leukemia

Researchers in Japan have identified a recurring fusion gene associated with poor prognosis in pediatric T-cell lymphoblastic leukemia.

Two Letters Added To The Genetic Alphabet

Scientists have determined the structures of two artificial DNA bases, Ds and Px, which have expanded the genetic code.

Targeted Delivery Of CRISPR Into Bone Tumors

Scientists in Hong Kong have developed a method to carry the CRISPR/Cas9 gene editing system into bone tumors, thus enabling therapeutic gene editing.